An HIV/AIDS vaccine developed in Canada has passed safety tests in animals and the researchers are awaiting approval to begin human trials in the U.S.
“It is a very important milestone for us,” said Yong Kang, a professor of microbiology at the University of Western Ontario in London who has been working on the vaccine for 20 years.
Kang said he expects to get the go-ahead soon from the U.S. Food and Drug Administration to begin human toxicology tests and two phases of clinical trials in the United States.
